ArticleLiver cancer2025

Consensus of Chinese Experts on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma: 2023 Update.

Xinyu Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.